Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Cancer, Ovarian Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02081495
What this trial is testing

DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 35
Not applicableStudy completedNCT04626895
What this trial is testing

Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers

Who this might be right for
Breast CancerOvarian CancerGynecologic Neoplasm+1 more
Medstar Health Research Institute 15
Not applicableLooking for participantsNCT06829654
What this trial is testing

Cryopreserved Ovarian Tissue Transplantation in Patients Who Have Survived Sarcomas and Hematological Tumors

Who this might be right for
SarcomasHaematological Malignancies
IRCCS Azienda Ospedaliero-Universitaria di Bologna 80
Early research (Phase 1)Active Not RecruitingNCT03017131
What this trial is testing

Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Roswell Park Cancer Institute 9
Not applicableStudy completedNCT03471572
What this trial is testing

Study to Assess Prevalence of BRCA1 and BRCA2 Mutation Among Ovarian, Primary Peritoneal and Fallopian Tube Cancer Patients in India

Who this might be right for
Ovarian Cancer
AstraZeneca 240
Not applicableUnknownNCT03979339
What this trial is testing

Feasibility of a New Technology for Isolating Circulating Tumour Cells

Who this might be right for
HER2-positive Metastatic Breast CancerOvarian CancerHormone-resistant Prostate Cancer+1 more
Centre Oscar Lambret 76
Not applicableLooking for participantsNCT06378905
What this trial is testing

Cukurova Score Validation Study

Who this might be right for
Epithelial Ovarian CancerPrimary Cytoreduction
Cukurova University 130
Testing effectiveness (Phase 2)UnknownNCT05976295
What this trial is testing

Efficacy of Jianpi Qushi Huatan Decoction in the Treatment of Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome
Jiangxi University of Traditional Chinese Medicine 68
Large-scale testing (Phase 3)Study completedNCT01857466
What this trial is testing

Ovarian Reserve After Ovarian Hemostasis by Floseal Matrix

Who this might be right for
Ovarian Cysts
CHA University 100
Not applicableStudy completedNCT01150539
What this trial is testing

Effects of Exercise for Overweight Women With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary SyndromeObesity
Pennington Biomedical Research Center 8
Post-approval studies (Phase 4)Study completedNCT04700839
What this trial is testing

SGLT2 Inhibitors in Patients With PCOS

Who this might be right for
Polycystic Ovary Syndrome
Shanghai 10th People's Hospital 68
Testing effectiveness (Phase 2)Ended earlyNCT02923739
What this trial is testing

Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube AdenocarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+17 more
M.D. Anderson Cancer Center 9
Testing effectiveness (Phase 2)UnknownNCT00838656
What this trial is testing

Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Warwick Medical School 88
Early research (Phase 1)Active Not RecruitingNCT03860272
What this trial is testing

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

Who this might be right for
Advanced CancerAngiosarcomaColorectal Cancer Without Liver Metastases+5 more
Agenus Inc. 499
Testing effectiveness (Phase 2)Study completedNCT01003483
What this trial is testing

Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients

Who this might be right for
Obesity
Yazd Research & Clinical Center for Infertility 80
Testing effectiveness (Phase 2)Ended earlyNCT04999605
What this trial is testing

AK112 Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsRecurrent Ovarian CarcinomaRelapsed Ovarian Cancer+1 more
Akeso 8
Post-approval studies (Phase 4)Ended earlyNCT04289805
What this trial is testing

Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)

Who this might be right for
Breast Neoplasm Malignant Female
Erasme University Hospital 96
Testing effectiveness (Phase 2)Study completedNCT01146795
What this trial is testing

Neoadjuvant Therapy for Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
Jason D. Wright 32
Early research (Phase 1)Ended earlyNCT05274451
What this trial is testing

Investigate LYL797 in Adults With Solid Tumors

Who this might be right for
Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more
Lyell Immunopharma, Inc. 57
Early research (Phase 1)Study completedNCT02475772
What this trial is testing

A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis

Who this might be right for
Ovarian Cancer
Clemens Tempfer 15
Next Page